| CLA1688 |
|
2408850-14-4 |
埃納妥單抗
Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)
-
|
需詢價(jià) |
— |
|
|
|
| CLA1678 |
|
2329669-78-3 |
帕那利單抗
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1666 |
|
2329669-72-7 |
沃達(dá)利單抗
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab；XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1634 |
|
2226212-40-2 |
塔奎妥單抗
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab； JNJ-64407564； JNJ-7564)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1610 |
|
2413817-97-5 |
格瑞妥單抗
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab； AMG 910; )
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1601 |
|
1801338-64-6 |
奧尼妥單抗
Anti-Human CD3ExCD20 Bispecific Antibody(Odronextamab)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1589 |
|
2134641-34-0 |
艾可瑞妥單抗
Anti-Human CD3ExCD20 (Epcoritamab; GEN3013)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1578 |
|
2171511-58-1 |
埃萬妥單抗
Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1553 |
|
2119595-80-9 |
特立妥單抗
Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab )
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1510 |
|
2101242-53-7 |
賽必妥單抗
Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1508 |
|
1607793-29-2 |
法瑞西單抗
Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1500 |
|
1969309-56-5 |
澤妥珠單抗
Anti-Human Her2xHer3 (Zenocutuzumab; MCLA-128; PB4188; R040517)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1489 |
|
1905409-39-3 |
莫妥珠單抗
Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A； R07030816；CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1401 |
|
1610943-06-0 |
依米賽珠單抗；艾美賽珠單抗
Anti-Human F9xF10 Bispecific Antibody(Emicizumab；RO 5534262, ACE 910；RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1389 |
|
1509928-04-4 |
艾司妥單抗
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| CLA1082 |
|
853426-35-4 |
蘭妥莫單抗；貝林妥歐單抗；博納吐單抗
Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific;)
3-5days
95+%
|
￥8600.00 |
— |
|
|
|
| CLA1659 |
|
2229047-91-8 |
格菲妥單抗
Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)
3-5days
95+%
|
￥4560.00 |
— |
|
|
|
| CLA1494 |
|
2394841-59-7 |
卡度尼利單抗
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Cadonilimab)
-
95+%
|
需詢價(jià) |
— |
|
|
|
